CA2403784A1 - Binding compounds and methods for identifying binding compounds - Google Patents

Binding compounds and methods for identifying binding compounds Download PDF

Info

Publication number
CA2403784A1
CA2403784A1 CA002403784A CA2403784A CA2403784A1 CA 2403784 A1 CA2403784 A1 CA 2403784A1 CA 002403784 A CA002403784 A CA 002403784A CA 2403784 A CA2403784 A CA 2403784A CA 2403784 A1 CA2403784 A1 CA 2403784A1
Authority
CA
Canada
Prior art keywords
molecule
binding
cxc
receptor
cxcr4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002403784A
Other languages
English (en)
French (fr)
Inventor
John J. Nestor, Jr.
Carol J. Wilson
Christina A. Tan Hehir
Steven A. Kates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Consensus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/813,653 external-priority patent/US20020064770A1/en
Priority claimed from US09/813,651 external-priority patent/US20030018438A1/en
Priority claimed from US09/813,448 external-priority patent/US20020142346A1/en
Application filed by Consensus Pharmaceuticals Inc filed Critical Consensus Pharmaceuticals Inc
Publication of CA2403784A1 publication Critical patent/CA2403784A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Endocrinology (AREA)
CA002403784A 2000-03-21 2001-03-21 Binding compounds and methods for identifying binding compounds Abandoned CA2403784A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US19129900P 2000-03-21 2000-03-21
US19099600P 2000-03-21 2000-03-21
US19094600P 2000-03-21 2000-03-21
US60/191,299 2000-03-21
US60/190,996 2000-03-21
US60/190,946 2000-03-21
US09/813,653 US20020064770A1 (en) 2000-03-21 2001-03-20 Binding compounds and methods for identifying binding compounds
US09/813,448 2001-03-20
US09/813,651 US20030018438A1 (en) 2000-03-21 2001-03-20 Binding compounds and methods for identifying binding compounds
US09/813,448 US20020142346A1 (en) 2000-03-21 2001-03-20 Binding compounds and methods for identifying binding compounds
US09/813,653 2001-03-20
US09/813,651 2001-03-20
PCT/US2001/009160 WO2001070768A2 (en) 2000-03-21 2001-03-21 Receptor-binding compounds and method for identifying them

Publications (1)

Publication Number Publication Date
CA2403784A1 true CA2403784A1 (en) 2001-09-27

Family

ID=27558818

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002403784A Abandoned CA2403784A1 (en) 2000-03-21 2001-03-21 Binding compounds and methods for identifying binding compounds
CA002403788A Abandoned CA2403788A1 (en) 2000-03-21 2001-03-21 Receptor-binding compounds and methods for identifying them
CA002404139A Abandoned CA2404139A1 (en) 2000-03-21 2001-03-21 Binding compounds and methods for identifying binding compounds

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA002403788A Abandoned CA2403788A1 (en) 2000-03-21 2001-03-21 Receptor-binding compounds and methods for identifying them
CA002404139A Abandoned CA2404139A1 (en) 2000-03-21 2001-03-21 Binding compounds and methods for identifying binding compounds

Country Status (5)

Country Link
EP (3) EP1268520A2 (de)
JP (2) JP2003528319A (de)
AU (3) AU2001247675A1 (de)
CA (3) CA2403784A1 (de)
WO (3) WO2001070765A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005056581A2 (en) * 2003-12-10 2005-06-23 Universite De Lausanne Peptide able to specifically bind a chemokine receptor and use thereof
CN101036057A (zh) * 2004-10-04 2007-09-12 阿尔卡米亚有限公司 选择性抑制剂
GB0724860D0 (en) * 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
US8409837B2 (en) * 2010-08-19 2013-04-02 Probiodrug Ag Crystal structure of glutaminyl cyclase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532167A (en) * 1994-01-07 1996-07-02 Beth Israel Hospital Substrate specificity of protein kinases

Also Published As

Publication number Publication date
WO2001070765A1 (en) 2001-09-27
CA2403788A1 (en) 2001-09-27
AU2001247674A1 (en) 2001-10-03
CA2404139A1 (en) 2001-09-27
WO2001070768A2 (en) 2001-09-27
WO2001070768A3 (en) 2002-03-14
JP2003528319A (ja) 2003-09-24
WO2001071346A2 (en) 2001-09-27
JP2004502134A (ja) 2004-01-22
EP1268520A2 (de) 2003-01-02
WO2001070765A9 (en) 2003-02-06
WO2001071346A3 (en) 2002-09-12
AU2001247675A1 (en) 2001-10-03
AU2001253870A1 (en) 2001-10-03
EP1268523A2 (de) 2003-01-02
EP1268521A1 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
US8389480B2 (en) G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
JPH06508742A (ja) 組換えトロンビンレセプターおよびそれに関連した薬剤
IE84069B1 (en) Recombinant thrombin receptor and related pharmaceuticals
BRPI0707920A2 (pt) peptìdeo monomérico, peptìdeo multimérico o compreendendo, seu uso, peptìdeo dimérico, fusão e composição farmacêutica compreendendo o mesmo, bem como métodos de detecção de fcrn in vitro, sinterização de um dìmero de peptìdeo e para purificação de fcrn
WO1995025957A1 (en) HUMAN C5a ANTAGONISTS AND AGONISTS
WO1998018456A1 (en) Protease-activated receptor 3 and uses thereof
WO2006028393A1 (en) Novel peptides and methods for the treatment of inflammatory disease
US20020064770A1 (en) Binding compounds and methods for identifying binding compounds
JP2003503426A (ja) ＦＶＩＩａアンタゴニスト
WO2002057313A2 (en) Receptor-binding compounds and methods for identifying them
US20030167129A1 (en) Binding compounds and methods for identifying binding compounds
JP2003521521A (ja) ウイルス性ケモカインｖＭＩＰ−ＩＩのＮ末端に由来する、ＣＸＣＲ４の新規ペプチド性拮抗物質
JP4813720B2 (ja) ヒト循環ウイルス阻害ペプチド（ｖｉｒｉｐ）及びその使用
CA2403784A1 (en) Binding compounds and methods for identifying binding compounds
AU783087B2 (en) Peptide antagonists of factor VIIA
US20030018438A1 (en) Binding compounds and methods for identifying binding compounds
US20020142346A1 (en) Binding compounds and methods for identifying binding compounds
EP0524173B1 (de) Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid
JP2002527093A (ja) コンツラキン−ｇ、そのアナログおよびそのための使用
US20050148028A1 (en) Scaffolded fusion polypeptides and compositions and methods for making the same
CA2252369A1 (en) Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors
CA2274305A1 (en) Novel trh receptor
WO2004106370A1 (en) M11l derived peptides and therapeutic use thereof
WO1995004756A1 (en) Complement inhibitor proteins of non-human primates
WO2005056581A2 (en) Peptide able to specifically bind a chemokine receptor and use thereof

Legal Events

Date Code Title Description
FZDE Dead